Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Buzzetti

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nature Biomedical Engineering|December 22, 2023
Assessing the toxicity of bispecific antibodiesMarta Buzzetti, Marco Gerlinger
Expert Review of Endocrinology & Metabolism|August 1, 2018
miRNAs in bone metastasisDouglas G Cheung, Marta Buzzetti, Gianpiero Di Leva
Scientific Reports|March 9, 2021
Pre-therapeutic efficacy of the CDK inhibitor dinaciclib in medulloblastoma cellsMarta Buzzetti, Sonia Morlando, Dimitrios Solomos, et al.
Scientific Reports|February 5, 2025
Author Correction: Pre-therapeutic efficacy of the CDK inhibitor dinaciclib in medulloblastoma cellsMarta Buzzetti, Sonia Morlando, Dimitrios Solomos, et al.
Disease Markers|January 11, 2019
A Specific Circulating MicroRNA Cluster Is Associated to Late Differential Cardiac Response to Doxorubicin-Induced Cardiotoxicity <i>In Vivo</i>Clarissa Ruggeri, Sonia Gioffré, Mattia Chiesa, et al.
Cell Genomics|May 20, 2025
Phenotypic heterogeneity and plasticity in colorectal cancer metastasisSamuel Ogden, Nasrine Metic, Ozen Leylek, et al.
Biomedicines|December 16, 2020
Differential Role of Circulating microRNAs to Track Progression and Pre-Symptomatic Stage of Chronic Heart Failure: A Pilot StudyYuri D'Alessandra, Mattia Chiesa, Maria Cristina Carena, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 20, 2018
Plasmatic and chamber-specific modulation of cardiac microRNAs in an acute model of DOX-induced cardiotoxicitySonia Gioffré, Veronica Ricci, Chiara Vavassori, et al.
EMBO Molecular Medicine|June 20, 2020
Vulnerability of drug-resistant EML4-ALK rearranged lung cancer to transcriptional inhibitionAthanasios R Paliouras, Marta Buzzetti, Lei Shi, et al.
The Journal of Pathology|November 15, 2023
Genetic and immune landscape evolution in MMR-deficient colorectal cancerBenjamin R Challoner, Andrew Woolston, David Lau, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nature Biomedical Engineering|December 22, 2023
Assessing the toxicity of bispecific antibodiesMarta Buzzetti, Marco Gerlinger
Expert Review of Endocrinology & Metabolism|August 1, 2018
miRNAs in bone metastasisDouglas G Cheung, Marta Buzzetti, Gianpiero Di Leva
Scientific Reports|March 9, 2021
Pre-therapeutic efficacy of the CDK inhibitor dinaciclib in medulloblastoma cellsMarta Buzzetti, Sonia Morlando, Dimitrios Solomos, et al.
Scientific Reports|February 5, 2025
Author Correction: Pre-therapeutic efficacy of the CDK inhibitor dinaciclib in medulloblastoma cellsMarta Buzzetti, Sonia Morlando, Dimitrios Solomos, et al.
Disease Markers|January 11, 2019
A Specific Circulating MicroRNA Cluster Is Associated to Late Differential Cardiac Response to Doxorubicin-Induced Cardiotoxicity <i>In Vivo</i>Clarissa Ruggeri, Sonia Gioffré, Mattia Chiesa, et al.
Cell Genomics|May 20, 2025
Phenotypic heterogeneity and plasticity in colorectal cancer metastasisSamuel Ogden, Nasrine Metic, Ozen Leylek, et al.
Biomedicines|December 16, 2020
Differential Role of Circulating microRNAs to Track Progression and Pre-Symptomatic Stage of Chronic Heart Failure: A Pilot StudyYuri D'Alessandra, Mattia Chiesa, Maria Cristina Carena, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 20, 2018
Plasmatic and chamber-specific modulation of cardiac microRNAs in an acute model of DOX-induced cardiotoxicitySonia Gioffré, Veronica Ricci, Chiara Vavassori, et al.
EMBO Molecular Medicine|June 20, 2020
Vulnerability of drug-resistant EML4-ALK rearranged lung cancer to transcriptional inhibitionAthanasios R Paliouras, Marta Buzzetti, Lei Shi, et al.
The Journal of Pathology|November 15, 2023
Genetic and immune landscape evolution in MMR-deficient colorectal cancerBenjamin R Challoner, Andrew Woolston, David Lau, et al.
Pageof 1